Neuronetics (STIM) Equity Average (2018 - 2026)

Neuronetics (STIM) has 9 years of Equity Average data on file, last reported at $19.8 million in Q1 2026.

• Quarterly Equity Average fell 44.62% year-over-year to $19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.8 million (down 44.62% YoY) and the FY2025 annual result came in at $29.0 million, down 12.05% from the prior year.
• Equity Average retreated to $19.8 million in Q1 2026 per STIM's latest filing, from $26.8 million in the prior quarter.
• Across five years, Equity Average topped out at $80.9 million in Q1 2022 and bottomed at $14.4 million in Q3 2024.
• The 5-year median for Equity Average is $35.7 million (2025), against an average of $40.8 million.
• The widest annual swing landed in 2024, when Equity Average tumbled 65.51%; it then surged 104.62% in 2025.
• Tracing STIM's Equity Average over 5 years: stood at $60.0 million in 2022, then sank by 39.92% to $36.1 million in 2023, then slumped by 42.91% to $20.6 million in 2024, then surged by 30.15% to $26.8 million in 2025, then declined by 26.29% to $19.8 million in 2026.
• Per Business Quant, the three latest STIM Equity Average figures stand at $19.8 million (Q1 2026), $26.8 million (Q4 2025), and $29.4 million (Q3 2025).

Peer Comparison